MXRA8 Protein, Human (HEK293, His)
Based on 1 Customer Validation
The MXRA8 protein is a transmembrane regulator that may interact with the integrin ITGAV:ITGB3 to affect various signaling pathways. It inhibits osteoclastogenesis, promotes chondrogenesis, and stimulates the formation of primary cilia in chondrocytes. MXRA8 Protein, Human (HEK293, His) is the recombinant human-derived MXRA8 protein, expressed by HEK293 , with C-His labeled tag.
- Species: Human
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
Description
The MXRA8 protein is a transmembrane regulator that may interact with the integrin ITGAV:ITGB3 to affect various signaling pathways. It inhibits osteoclastogenesis, promotes chondrogenesis, and stimulates the formation of primary cilia in chondrocytes. MXRA8 Protein, Human (HEK293, His) is the recombinant human-derived MXRA8 protein, expressed by HEK293 , with C-His labeled tag.
Background
MXRA8, a transmembrane protein, exerts its regulatory influence on various signaling pathways, likely through interaction with integrin ITGAV:ITGB3. This interaction facilitates heterophilic cell-cell interactions and modulates osteoclastogenesis downstream of TNFSF11/RANKL and CSF1, potentially by dampening signaling via integrin ITGB3 and MAP kinase p38. In the context of cartilage formation, MXRA8 promotes the proliferation and maturation of growth plate chondrocytes, stimulates primary cilia formation, and enhances the expression of hedgehog signaling pathway genes, including IHH. Furthermore, MXRA8 plays a role in angiogenesis by suppressing endothelial cell migration, promoting apoptosis, and inhibiting VEGF-induced activation of AKT and p38 MAP kinase. Additionally, MXRA8 inhibits integrin ITGAV:ITGB3 signaling and PTK2/FAK activation in response to VTN. It may also contribute to the maturation and maintenance of the blood-brain barrier. In the context of microbial infection, MXRA8 serves as a receptor for arthritogenic alphaviruses, contributing to their pathogenesis.
Technical Parameters
-
Species Human
-
Source HEK293
-
Tag C-8*His
-
Accession
Q9BRK3-1 (V20-Q341)
-
Molecular Construction
-
N-term
-
MXRA8 (V20-Q341)
Accession # Q9BRK3-1 -
8*His
-
C-term
-
-
Protein Length
Extracellular Domain
-
Synonyms
MXRA8; Matrix-Remodelling Associated 8; Matrix Remodeling Associated 8; DKFZp586E2023; Limitrin; Matrix-Remodeling-Associated Protein 8; Matrix Remodeling-Associated Protein 8; ASP3
-
AA Sequence
VLLHSGSSVPAAAGSSVVSESAVSWEAGARAVLRCQSPRMVWTQDRLHDRQRVLHWDLRGPGGGPARRLLDLYSAGEQRVYEARDRGRLELSASAFDDGNFSLLIRAVEETDAGLYTCNLHHHYCHLYESLAVRLEVTDGPPATPAYWDGEKEVLAVARGAPALLTCVNRGHVWTDRHVEEAQQVVHWDRQPPGVPHDRADRLLDLYASGERRAYGPLFLRDRVAVGADAFERGDFSLRIEPLEVADEGTYSCHLHHHYCGLHERRVFHLTVAEPHAEPPPRGSPGNGSSHSGAPGPDPTLARGHNVINVIVPESRAHFFQQ
-
Predicted Molecular Mass
36.7 kDa
-
Molecular Weight
Approximately 40-50 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.
-
Glycosylation
Yes
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder.
Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 8% trehalose.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O.
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (237 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)